2 min read
2024 ASCO Annual Meeting
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
The Science-First CRO™ and Consultancy Ready to...
1 min read
Veristat, a full-service CRO, can guide you through the planning and development process to help you successfully bring a new
myeloma cancer treatment to market. With 41% of our work in oncology trials and extensive experience with myeloma, Veristat can help advance your compound through the submission process. Our teams will collaborate to build the optimal program based upon the science of your product, while providing key functional services, including trial design, clinical monitoring, data management, medical writing and statistical consultation with regulatory representation.
|
Contact our team to learn more about our oncology experience, the work we have performed in the area of myeloma and how we can help you.
|
WORKING TOGETHER. The Veristat Oncology team:
Through application of cutting-edge research, novel trial designs, and innovative approaches, Veristat delivers excellence throughout every aspect of an oncology trial. |
2 min read
May 3, 2024 Veristat Events
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
The Science-First CRO™ and Consultancy Ready to...
1 min read
Apr 9, 2024 Veristat Events
Meet the Veristat team at Booth #3, April 17th and 18th in Boston
The Science-First CRO™ and Consultancy Ready to...